What are you looking for?
All Filters
Therapeutic Area
Therapeutic Area
Date Published
Date published

Bridge To Knowledge - Incorporating BTKis into the CSU Treatment Landscape (Live Webinar)

Tuesday November 25 • 7:00pm - 8:00 pm (Eastern Time)

Register below to join the live event! Please accept our website cookies to ensure a seamless experience.

Program Objectives

  • Discuss unmet needs in CSU management and the limitations of current treatment options.
  • Describe pathogenesis of CSU and how the mechanism of action (MOA) of BTKis targets the pathophysiology of CSU and links to safety and efficacy.
  • Review updated guidelines for the management of CSU and the positioning of emerging treatments including Bruton’s tyrosine kinase (BTK) inhibitors and other pipeline therapies.
  • Analyze latest clinical trial data for BTK inhibitors in CSU and discuss their potential role in addressing current unmet treatment needs and other new treatments.

 

Meet the Speakers

Dr Gordon Sussman headshot
Dr Irina Turchin

       Dr. Gordon Sussman

            Allergy

Dr. Gordon Sussman is a Professor of Medicine at the University of Toronto and an allergist at St. Michael’s Hospital. He was among the first to identify natural rubber latex allergy and contributed to strategies that helped curb the latex allergy epidemic of the 1980s. His research has shaped the understanding and treatment of chronic spontaneous urticaria (CSU), including early studies of omalizumab and insights into its autoimmune basis. Dr. Sussman has also led key research in hereditary angioedema and peanut anaphylaxis. More recently, he has identified and described cannabis-related allergies and continues to explore allergen cross-reactivity.

       Dr. Irina Turchin

            Dermatology

 Dr. Turchin is a community dermatologist in Fredericton, New Brunswick, and a dermatology consultant for the Horizon Health Network. She is also an assistant professor at Dalhousie University and a clinical investigator with Probity Medical Research. After earning her medical degree from the University of Calgary and completing residency at McGill, she has practiced dermatology in New Brunswick since 2009. Active in clinical research since 2014, she has led trials on treatments for psoriasis, eczema, hidradenitis suppurativa, urticaria, and other skin conditions.

FA-11527297F